

The global Chromosomal Microarray Analysis (CMA) Testing market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
Chromosomal microarray analysis (CMA) is an emerging technology in the field of prenatal diagnosis. It can not only accurately detect whether the number of chromosomes and the structure of large fragments are abnormal,and it can detect microstructural variations such as microdeletions/microduplications,it has the advantages of high resolution, short detection cycle and objective results. However, CMA has certain limitations in the detection of balanced translocations, inversions, and low-level mosaicism.
This report is a detailed and comprehensive analysis for global Chromosomal Microarray Analysis (CMA) Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Chromosomal Microarray Analysis (CMA) Testing market size and forecasts, in consumption value ($ Million), 2020-2031
Global Chromosomal Microarray Analysis (CMA) Testing market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Chromosomal Microarray Analysis (CMA) Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Chromosomal Microarray Analysis (CMA) Testing market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Chromosomal Microarray Analysis (CMA) Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Chromosomal Microarray Analysis (CMA) Testing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Baylor Genetics, MedGenome Labs, Illumina Inc., CD Genomics, Thermo Fisher, Agilent, GeneDx, Quest Diagnostics, LabCorp, Lineagen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Chromosomal Microarray Analysis (CMA) Testing market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Single Nucleotide Polymorphism (SNP)
Comparative Genomic Hybridization (CGH)
Market segment by Application
Medical
Laboratory
Clinical
Others
Market segment by players, this report covers
Baylor Genetics
MedGenome Labs
Illumina Inc.
CD Genomics
Thermo Fisher
Agilent
GeneDx
Quest Diagnostics
LabCorp
Lineagen
Invitae
Centogene
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Chromosomal Microarray Analysis (CMA) Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Chromosomal Microarray Analysis (CMA) Testing, with revenue, gross margin, and global market share of Chromosomal Microarray Analysis (CMA) Testing from 2020 to 2025.
Chapter 3, the Chromosomal Microarray Analysis (CMA) Testing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Chromosomal Microarray Analysis (CMA) Testing market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Chromosomal Microarray Analysis (CMA) Testing.
Chapter 13, to describe Chromosomal Microarray Analysis (CMA) Testing research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Chromosomal Microarray Analysis (CMA) Testing by Type
1.3.1 Overview: Global Chromosomal Microarray Analysis (CMA) Testing Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Chromosomal Microarray Analysis (CMA) Testing Consumption Value Market Share by Type in 2024
1.3.3 Single Nucleotide Polymorphism (SNP)
1.3.4 Comparative Genomic Hybridization (CGH)
1.4 Global Chromosomal Microarray Analysis (CMA) Testing Market by Application
1.4.1 Overview: Global Chromosomal Microarray Analysis (CMA) Testing Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Medical
1.4.3 Laboratory
1.4.4 Clinical
1.4.5 Others
1.5 Global Chromosomal Microarray Analysis (CMA) Testing Market Size & Forecast
1.6 Global Chromosomal Microarray Analysis (CMA) Testing Market Size and Forecast by Region
1.6.1 Global Chromosomal Microarray Analysis (CMA) Testing Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Chromosomal Microarray Analysis (CMA) Testing Market Size by Region, (2020-2031)
1.6.3 North America Chromosomal Microarray Analysis (CMA) Testing Market Size and Prospect (2020-2031)
1.6.4 Europe Chromosomal Microarray Analysis (CMA) Testing Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Chromosomal Microarray Analysis (CMA) Testing Market Size and Prospect (2020-2031)
1.6.6 South America Chromosomal Microarray Analysis (CMA) Testing Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Chromosomal Microarray Analysis (CMA) Testing Market Size and Prospect (2020-2031)
2 Company Profiles
2.1 Baylor Genetics
2.1.1 Baylor Genetics Details
2.1.2 Baylor Genetics Major Business
2.1.3 Baylor Genetics Chromosomal Microarray Analysis (CMA) Testing Product and Solutions
2.1.4 Baylor Genetics Chromosomal Microarray Analysis (CMA) Testing Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Baylor Genetics Recent Developments and Future Plans
2.2 MedGenome Labs
2.2.1 MedGenome Labs Details
2.2.2 MedGenome Labs Major Business
2.2.3 MedGenome Labs Chromosomal Microarray Analysis (CMA) Testing Product and Solutions
2.2.4 MedGenome Labs Chromosomal Microarray Analysis (CMA) Testing Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 MedGenome Labs Recent Developments and Future Plans
2.3 Illumina Inc.
2.3.1 Illumina Inc. Details
2.3.2 Illumina Inc. Major Business
2.3.3 Illumina Inc. Chromosomal Microarray Analysis (CMA) Testing Product and Solutions
2.3.4 Illumina Inc. Chromosomal Microarray Analysis (CMA) Testing Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Illumina Inc. Recent Developments and Future Plans
2.4 CD Genomics
2.4.1 CD Genomics Details
2.4.2 CD Genomics Major Business
2.4.3 CD Genomics Chromosomal Microarray Analysis (CMA) Testing Product and Solutions
2.4.4 CD Genomics Chromosomal Microarray Analysis (CMA) Testing Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 CD Genomics Recent Developments and Future Plans
2.5 Thermo Fisher
2.5.1 Thermo Fisher Details
2.5.2 Thermo Fisher Major Business
2.5.3 Thermo Fisher Chromosomal Microarray Analysis (CMA) Testing Product and Solutions
2.5.4 Thermo Fisher Chromosomal Microarray Analysis (CMA) Testing Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Thermo Fisher Recent Developments and Future Plans
2.6 Agilent
2.6.1 Agilent Details
2.6.2 Agilent Major Business
2.6.3 Agilent Chromosomal Microarray Analysis (CMA) Testing Product and Solutions
2.6.4 Agilent Chromosomal Microarray Analysis (CMA) Testing Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Agilent Recent Developments and Future Plans
2.7 GeneDx
2.7.1 GeneDx Details
2.7.2 GeneDx Major Business
2.7.3 GeneDx Chromosomal Microarray Analysis (CMA) Testing Product and Solutions
2.7.4 GeneDx Chromosomal Microarray Analysis (CMA) Testing Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 GeneDx Recent Developments and Future Plans
2.8 Quest Diagnostics
2.8.1 Quest Diagnostics Details
2.8.2 Quest Diagnostics Major Business
2.8.3 Quest Diagnostics Chromosomal Microarray Analysis (CMA) Testing Product and Solutions
2.8.4 Quest Diagnostics Chromosomal Microarray Analysis (CMA) Testing Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Quest Diagnostics Recent Developments and Future Plans
2.9 LabCorp
2.9.1 LabCorp Details
2.9.2 LabCorp Major Business
2.9.3 LabCorp Chromosomal Microarray Analysis (CMA) Testing Product and Solutions
2.9.4 LabCorp Chromosomal Microarray Analysis (CMA) Testing Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 LabCorp Recent Developments and Future Plans
2.10 Lineagen
2.10.1 Lineagen Details
2.10.2 Lineagen Major Business
2.10.3 Lineagen Chromosomal Microarray Analysis (CMA) Testing Product and Solutions
2.10.4 Lineagen Chromosomal Microarray Analysis (CMA) Testing Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Lineagen Recent Developments and Future Plans
2.11 Invitae
2.11.1 Invitae Details
2.11.2 Invitae Major Business
2.11.3 Invitae Chromosomal Microarray Analysis (CMA) Testing Product and Solutions
2.11.4 Invitae Chromosomal Microarray Analysis (CMA) Testing Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Invitae Recent Developments and Future Plans
2.12 Centogene
2.12.1 Centogene Details
2.12.2 Centogene Major Business
2.12.3 Centogene Chromosomal Microarray Analysis (CMA) Testing Product and Solutions
2.12.4 Centogene Chromosomal Microarray Analysis (CMA) Testing Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Centogene Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Chromosomal Microarray Analysis (CMA) Testing Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Chromosomal Microarray Analysis (CMA) Testing by Company Revenue
3.2.2 Top 3 Chromosomal Microarray Analysis (CMA) Testing Players Market Share in 2024
3.2.3 Top 6 Chromosomal Microarray Analysis (CMA) Testing Players Market Share in 2024
3.3 Chromosomal Microarray Analysis (CMA) Testing Market: Overall Company Footprint Analysis
3.3.1 Chromosomal Microarray Analysis (CMA) Testing Market: Region Footprint
3.3.2 Chromosomal Microarray Analysis (CMA) Testing Market: Company Product Type Footprint
3.3.3 Chromosomal Microarray Analysis (CMA) Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Chromosomal Microarray Analysis (CMA) Testing Consumption Value and Market Share by Type (2020-2025)
4.2 Global Chromosomal Microarray Analysis (CMA) Testing Market Forecast by Type (2026-2031)
5 Market Size Segment by Application
5.1 Global Chromosomal Microarray Analysis (CMA) Testing Consumption Value Market Share by Application (2020-2025)
5.2 Global Chromosomal Microarray Analysis (CMA) Testing Market Forecast by Application (2026-2031)
6 North America
6.1 North America Chromosomal Microarray Analysis (CMA) Testing Consumption Value by Type (2020-2031)
6.2 North America Chromosomal Microarray Analysis (CMA) Testing Market Size by Application (2020-2031)
6.3 North America Chromosomal Microarray Analysis (CMA) Testing Market Size by Country
6.3.1 North America Chromosomal Microarray Analysis (CMA) Testing Consumption Value by Country (2020-2031)
6.3.2 United States Chromosomal Microarray Analysis (CMA) Testing Market Size and Forecast (2020-2031)
6.3.3 Canada Chromosomal Microarray Analysis (CMA) Testing Market Size and Forecast (2020-2031)
6.3.4 Mexico Chromosomal Microarray Analysis (CMA) Testing Market Size and Forecast (2020-2031)
7 Europe
7.1 Europe Chromosomal Microarray Analysis (CMA) Testing Consumption Value by Type (2020-2031)
7.2 Europe Chromosomal Microarray Analysis (CMA) Testing Consumption Value by Application (2020-2031)
7.3 Europe Chromosomal Microarray Analysis (CMA) Testing Market Size by Country
7.3.1 Europe Chromosomal Microarray Analysis (CMA) Testing Consumption Value by Country (2020-2031)
7.3.2 Germany Chromosomal Microarray Analysis (CMA) Testing Market Size and Forecast (2020-2031)
7.3.3 France Chromosomal Microarray Analysis (CMA) Testing Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Chromosomal Microarray Analysis (CMA) Testing Market Size and Forecast (2020-2031)
7.3.5 Russia Chromosomal Microarray Analysis (CMA) Testing Market Size and Forecast (2020-2031)
7.3.6 Italy Chromosomal Microarray Analysis (CMA) Testing Market Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Chromosomal Microarray Analysis (CMA) Testing Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Chromosomal Microarray Analysis (CMA) Testing Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Chromosomal Microarray Analysis (CMA) Testing Market Size by Region
8.3.1 Asia-Pacific Chromosomal Microarray Analysis (CMA) Testing Consumption Value by Region (2020-2031)
8.3.2 China Chromosomal Microarray Analysis (CMA) Testing Market Size and Forecast (2020-2031)
8.3.3 Japan Chromosomal Microarray Analysis (CMA) Testing Market Size and Forecast (2020-2031)
8.3.4 South Korea Chromosomal Microarray Analysis (CMA) Testing Market Size and Forecast (2020-2031)
8.3.5 India Chromosomal Microarray Analysis (CMA) Testing Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Chromosomal Microarray Analysis (CMA) Testing Market Size and Forecast (2020-2031)
8.3.7 Australia Chromosomal Microarray Analysis (CMA) Testing Market Size and Forecast (2020-2031)
9 South America
9.1 South America Chromosomal Microarray Analysis (CMA) Testing Consumption Value by Type (2020-2031)
9.2 South America Chromosomal Microarray Analysis (CMA) Testing Consumption Value by Application (2020-2031)
9.3 South America Chromosomal Microarray Analysis (CMA) Testing Market Size by Country
9.3.1 South America Chromosomal Microarray Analysis (CMA) Testing Consumption Value by Country (2020-2031)
9.3.2 Brazil Chromosomal Microarray Analysis (CMA) Testing Market Size and Forecast (2020-2031)
9.3.3 Argentina Chromosomal Microarray Analysis (CMA) Testing Market Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Chromosomal Microarray Analysis (CMA) Testing Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Chromosomal Microarray Analysis (CMA) Testing Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Chromosomal Microarray Analysis (CMA) Testing Market Size by Country
10.3.1 Middle East & Africa Chromosomal Microarray Analysis (CMA) Testing Consumption Value by Country (2020-2031)
10.3.2 Turkey Chromosomal Microarray Analysis (CMA) Testing Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Chromosomal Microarray Analysis (CMA) Testing Market Size and Forecast (2020-2031)
10.3.4 UAE Chromosomal Microarray Analysis (CMA) Testing Market Size and Forecast (2020-2031)
11 Market Dynamics
11.1 Chromosomal Microarray Analysis (CMA) Testing Market Drivers
11.2 Chromosomal Microarray Analysis (CMA) Testing Market Restraints
11.3 Chromosomal Microarray Analysis (CMA) Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Chromosomal Microarray Analysis (CMA) Testing Industry Chain
12.2 Chromosomal Microarray Analysis (CMA) Testing Upstream Analysis
12.3 Chromosomal Microarray Analysis (CMA) Testing Midstream Analysis
12.4 Chromosomal Microarray Analysis (CMA) Testing Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Baylor Genetics
MedGenome Labs
Illumina Inc.
CD Genomics
Thermo Fisher
Agilent
GeneDx
Quest Diagnostics
LabCorp
Lineagen
Invitae
Centogene
Ìý
Ìý
*If Applicable.